Here's Why We're Not At All Concerned With Vector Science and Therapeutics' (CVE:PAIN) Cash Burn Situation

But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. Given this risk, we thought we'd take a ...

Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or "Company") today announced the appointment of Dr. Alexander Dobranowski and Scott Kelly to its Board of Directors ("Board"), further ...

Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery

Vector Science & Therapeutics (the "Company") today announced the filing of a provisional patent application covering a novel catheter-based platform designed for intratumoral drug delivery research, ...

Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.): Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange

Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to ...

Vector Sciences & Therapeutics: Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery

Platform Integrates Three Research Modalities Targeting the Electrical Properties of Tumor Biology in Pancreatic Cancer MEQUON, Wis., May 1, 2026 /PRNewswire/ -- (TSXV: ...
The Globe and Mail

Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to ...